Yesterday at 23:32
Brazil recorded 1,109 deaths and 38,693 infected by the new coronavirus in the last 24 hours, totaling 5,7070 deaths and 1,313,667 confirmed cases since the beginning of the pandemic.
According to the Ministry of Health, the lethality of the disease in Brazil, the second country in the world with the most dead and infected, has fallen again, reaching 4.3%, at which time a possible relationship of 3,799 fatalities with covid-19 is still being investigated.
Also according to the guardianship, 443 of the 1,109 deaths occurred in the last three days, but were included in the data on Saturday.
Brazil now has an incidence of 27.2 deaths and 625.1 cases of the disease per 100,000 inhabitants, in a country with an estimated population of 210 million people.
Regarding the number of recovered, 715,905 infected people have recovered from the disease, while 540,692 patients remain under follow-up.
São Paulo, the richest and most populous state in the country, is the focus of the pandemic in Brazil, currently concentrating 14,263 fatalities and 265,581 confirmed cases. Rio de Janeiro is followed by 9,789 deaths and 108,803 people diagnosed.
The Brazilian Ministry of Health announced on Saturday a partnership for the national research and production of the vaccine against covid-19 developed by the University of Oxford, Uk, and the pharmaceutical AstraZeneca.
“The Federal Government sent a response to the British embassy and the president of the AstraZeneca laboratory accepting the proposal for a cooperation agreement on technological development and Access of Brazil to the vaccine for covid-19. The agreement provides for the purchase of lots of vaccine and technology transfer. If demonstrated effectiveness, there will be 100 million doses available to the Brazilian population,” the executive said in a statement.
In Brazil, the technology will be developed by the Oswaldo Cruz Foundation (Fiocruz), the largest medical research center in Latin America, linked to the Brazilian Ministry of Health.
For the National Secretary of Health Surveillance of the Brazilian Government, Arnaldo Correia de Medeiros, if the effectiveness of immunization is proven, it is estimated that early next year a vaccination campaign can be carried out, starting with the priority audiences, that is, by the population most vulnerable to covid-19.
“With the approved vaccine we will have coverage performed as part of Brazil’s expertise in national vaccination campaigns, in this case prioritizing more vulnerable audiences such as the elderly, people with comorbidities, health professionals, teachers, security professionals, indigenous people, public transportation drivers and people deprived of liberty,” Medeiros said.
“I would like to point out that after the United Kingdom, Brazil was the first to start studies of the efficacy of the vaccine against covid-19. It is the only clinical study of vaccines in Latin America,” said Camile Sachetti, Director of Science and Technology at the Ministry of Health.
The covid-19 pandemic has claimed more than 495,000 lives and affected more than 9.87 million people in 196 countries and territories, according to a report by French news agency AFP.
The disease is transmitted by a new coronavirus detected in late December in Wuhan, a city in central China.